Skip to main content

Crinetics Pharmaceuticals, Inc.

CRNXDelisted Sep 1, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001658247

Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Crinetics Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $120.0K in total
Insiders trading
1
Net value
−$120.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Crinetics Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Crinetics Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wierenga WendellDirector0Sep 1, 20262
Vivaldi Coelho RogerioDirector0Sep 1, 20264
Okey StephanieDirector0Sep 1, 20264
Nichols WestonDirector0Sep 1, 20262
Fust Matthew KDirector0Sep 1, 20263
Deardorf CarenDirector0Sep 1, 20262
Bedrosian Camille LDirector0Sep 1, 20262
Kalofonos IsabelChief Commercial Officer0Sep 1, 20263
Betz Stephen F.Chief Scientific Officer0Sep 1, 20264
Schilke TobinChief Financial & Infra. Ofcr.0Sep 1, 20264
Struthers Richard ScottPresident & CEO0Sep 1, 20267
Knight Jeff E.Chief Dev. & Operating Officer105,289Apr 10, 20263
Pizzuti DanaChief Med and Dev Officer66,837Dec 3, 20253
Wierenga WendallDirector116,146Jun 13, 20250
Wilson MarcCFO111,092Sep 30, 20240
Hassard JamesChief Commercial Officer29,259Jul 9, 20240
Krasner Alan SethChief Medical Officer43,210Oct 19, 20230
Edelman Joseph10% Owner5,321,032IndirectApr 18, 20220
Perceptive Advisors LLC10% Owner5,321,032IndirectApr 18, 20220
Perceptive Life Sciences Master Fund Ltd10% Owner5,321,032IndirectApr 18, 20220
Madan AjayChief Development Officer176,995Mar 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 13, 2021 (view filing)Jul 121 dayFust Matthew KDirectorSSale−5.00K$20.71−$103.5K−28.5%12.5K after
Jul 20, 2021 (view filing)Jul 191 dayFust Matthew KDirectorSSale−5.00K$19.50−$97.5K−28.5%12.5K after
Jul 27, 2021 (view filing)Jul 261 dayFust Matthew KDirectorSSale−5.00K$19.59−$98.0K−28.5%12.5K after
Sep 9, 2021 (view filing)Sep 72 daysStruthers Richard ScottPresident & CEOSSale−30.0K$25.00−$750.0K−25.0%90.0K after3 lots
Sep 9, 2021 (view filing)Sep 81 dayFust Matthew KDirectorSSale−6.05K$25.50−$154.2K−32.5%12.5K after
Oct 25, 2021 (view filing)Oct 214 daysBetz Stephen F.Chief Scientific OfficerSSale−1.04K$21.10−$22.0K−0.6%186.9K after
Oct 25, 2021 (view filing)2:47 PM ETOct 25Same dayEdelman Joseph and 2 others10% OwnerPPurchase+1.20M$19.80+$23.8M+30.3%5.16M after
Oct 28, 2021 (view filing)Oct 271 dayBetz Stephen F.Chief Scientific OfficerSSale−3.00K$24.00−$72.0K−1.6%183.9K after
Nov 3, 2021 (view filing)Nov 12 daysFust Matthew KDirectorSSale−8.95K$25.50−$228.3K−41.7%12.5K after
Nov 3, 2021 (view filing)Nov 12 daysBetz Stephen F.Chief Scientific OfficerSSale−5.67K$24.79−$140.5K−3.1%178.2K after
Nov 9, 2021 (view filing)Nov 5-84 daysBetz Stephen F.Chief Scientific OfficerSSale−16.5K$28.06−$463.0K−9.3%161.7K after2 lots
Nov 17, 2021 (view filing)Nov 152 daysBetz Stephen F.Chief Scientific OfficerSSale−5.67K$26.75−$151.6K−3.5%156.0K after
Nov 17, 2021 (view filing)Nov 161 dayBetz Stephen F.Chief Scientific OfficerSSale−1.50K$27.97−$42.0K−1.0%154.5K after
Dec 3, 2021 (view filing)Dec 12 daysBetz Stephen F.Chief Scientific OfficerSSale−5.67K$27.38−$155.2K−3.7%148.9K after
Dec 17, 2021 (view filing)Dec 152 daysBetz Stephen F.Chief Scientific OfficerSSale−5.67K$24.14−$136.8K−3.8%143.2K after
Dec 30, 2021 (view filing)Dec 282 daysBetz Stephen F.Chief Scientific OfficerSSale−3.00K$27.95−$83.8K−2.1%140.2K after
Jan 6, 2022 (view filing)Jan 33 daysLateBetz Stephen F.Chief Scientific OfficerSSale−7.17K$28.02−$200.8K−5.1%133.0K after
Jan 20, 2022 (view filing)Jan 182 daysBetz Stephen F.Chief Scientific OfficerSSale−4.17K$23.29−$97.1K−3.1%128.9K after
Jan 21, 2022 (view filing)Jan 192 daysKrasner Alan SethChief Medical OfficerSSale−6.70K$21.21−$142.1K−44.6%8.31K after
Feb 3, 2022 (view filing)Feb 12 daysBetz Stephen F.Chief Scientific OfficerSSale−3.12K$18.79−$58.7K−2.4%126.7K after
Feb 9, 2022 (view filing)Feb 72 daysMadan AjayChief Development OfficerSSale−13.4K$17.83−$239.1K−7.2%172.0K after
Feb 17, 2022 (view filing)Feb 152 daysBetz Stephen F.Chief Scientific OfficerSSale−3.12K$18.64−$58.2K−2.5%123.6K after
Mar 2, 2022 (view filing)Mar 11 dayBetz Stephen F.Chief Scientific OfficerSSale−3.12K$19.73−$61.6K−2.2%137.0K after
Mar 2, 2022 (view filing)Mar 11 dayMadan AjayChief Development OfficerSSale+9.00K$19.88+$178.9K+5.4%177.0K after
Mar 17, 2022 (view filing)Mar 152 daysBetz Stephen F.Chief Scientific OfficerSSale−3.12K$18.94−$59.1K−2.3%133.8K after
Apr 1, 2022 (view filing)Mar 31-Apr 11 dayBetz Stephen F.Chief Scientific OfficerSSale−8.33K$21.43−$178.5K−6.2%125.5K after2 lots
Apr 6, 2022 (view filing)Apr 42 daysBetz Stephen F.Chief Scientific OfficerSSale−9.00K$23.97−$215.7K−7.2%116.5K after
Apr 7, 2022 (view filing)Apr 52 daysStruthers Richard ScottPresident & CEOSSale−21.4K$25.34−$541.2K−2.4%869.4K after
Apr 15, 2022 (view filing)Apr 132 daysStruthers Richard ScottPresident & CEOSSale−138.6K$26.83−$3.72M−15.9%730.8K after3 lots
Apr 18, 2022 (view filing)5:39 PM ETApr 18Same dayEdelman Joseph and 2 others10% OwnerPPurchase+157.5K$22.22+$3.50M+3.1%5.32M after
Apr 21, 2022 (view filing)Apr 183 daysLateBetz Stephen F.Chief Scientific OfficerSSale−5.66K$25.81−$146.2K−4.9%110.8K after
May 4, 2022 (view filing)May 22 daysBetz Stephen F.Chief Scientific OfficerSSale−3.25K$20.10−$65.3K−2.9%107.6K after
Jul 15, 2022 (view filing)Jul 132 daysFust Matthew KDirectorSSale−5.70K$20.96−$119.5K−31.3%12.5K after
Jul 29, 2022 (view filing)Jul 263 daysLateKnight Jeff E.Chief Operating OfficerSSale−1.15K$20.70−$23.8K−18.9%4.95K after
Sep 6, 2022 (view filing)Sep 15 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$18.59−$58.1K−2.9%105.8K after
Sep 9, 2022 (view filing)Sep 72 daysBetz Stephen F.Chief Scientific OfficerSSale−1.04K$21.00−$21.9K−1.0%104.8K after
Sep 19, 2022 (view filing)Sep 154 daysBetz Stephen F.Chief Scientific OfficerSSale−4.17K$21.01−$87.6K−4.0%100.6K after
Oct 5, 2022 (view filing)Oct 32 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$19.64−$61.4K−3.1%97.5K after
Oct 19, 2022 (view filing)Oct 172 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$17.73−$55.4K−3.2%94.3K after
Nov 3, 2022 (view filing)Nov 12 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$18.52−$57.9K−3.3%91.2K after
Nov 17, 2022 (view filing)Nov 152 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$18.72−$58.5K−3.4%88.1K after
Dec 5, 2022 (view filing)Dec 14 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$17.84−$55.8K−3.5%85.0K after
Dec 19, 2022 (view filing)Dec 154 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$16.00−$50.0K−3.7%82.4K after
Jan 5, 2023 (view filing)Jan 32 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$18.35−$57.4K−3.8%79.3K after
Jan 19, 2023 (view filing)Jan 172 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$18.00−$56.3K−3.9%76.2K after
Jan 27, 2023 (view filing)Jan 252 daysBetz Stephen F.Chief Scientific OfficerSSale−8.34K$21.07−$175.6K−10.9%67.8K after
Feb 3, 2023 (view filing)Feb 12 daysBetz Stephen F.Chief Scientific OfficerSSale−3.13K$19.59−$61.2K−4.6%64.7K after
Apr 5, 2023 (view filing)Apr 5Same dayPizzuti DanaChief Development OfficerSSale−8.21K$16.15−$132.6K−64.6%4.50K after10b5-1
Jun 9, 2023 (view filing)Jun 81 dayVivaldi Coelho RogerioDirectorPPurchase+5.00K$22.06+$110.3KNew position5.00K after
Jun 21, 2023 (view filing)Jun 165 daysStruthers Richard ScottPresident & CEOSSale−50.0K$20.81−$1.04M−6.8%680.8K after10b5-1